Opportunity ID: 332560

General Information

Document Type: Grants Notice
Funding Opportunity Number: RFA-AI-21-019
Funding Opportunity Title: Radiation-Induced Immune Dysfunction (U01 Clinical Trial Not Allowed)
Opportunity Category: Discretionary
Opportunity Category Explanation:
Funding Instrument Type: Cooperative Agreement
Category of Funding Activity: Health
Category Explanation:
Expected Number of Awards:
Assistance Listings: 93.855 — Allergy and Infectious Diseases Research
Cost Sharing or Matching Requirement: No
Version: Synopsis 1
Posted Date: Apr 02, 2021
Last Updated Date: Apr 02, 2021
Original Closing Date for Applications: Aug 24, 2021
Current Closing Date for Applications: Aug 24, 2021
Archive Date: Sep 29, 2021
Estimated Total Program Funding:
Award Ceiling:
Award Floor:

Eligibility

Eligible Applicants: Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education
Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education
Private institutions of higher education
Special district governments
Others (see text field entitled “Additional Information on Eligibility” for clarification)
Native American tribal organizations (other than Federally recognized tribal governments)
County governments
Small businesses
State governments
Public and State controlled institutions of higher education
Native American tribal governments (Federally recognized)
City or township governments
For profit organizations other than small businesses
Independent school districts
Public housing authorities/Indian housing authorities
Additional Information on Eligibility: Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession; Non-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, are allowed.

Additional Information

Agency Name: National Institutes of Health
Description: Research funded by this initiative will examine the effects of radiation exposure on the immune system and explore possible treatments for radiation-induced immune dysfunction. Research gaps exist in understanding the mechanisms of injury and repair with regard to radiation-induced immune system dysfunction, and these gaps must be addressed to better develop MCMs for radiation exposure. Through this initiative, the NIAID Radiation and Nuclear Countermeasures Program (RNCP) will support development of animal models for immune-targeted radiation injuries, studies to better understand radiation impacts on the immune system (including immune system-mediated multi-organ injury), identification of immune-specific pathways targeted by radiation, as well as biomarkers of exposure and mitigators/treatments that target immune-related radiation response pathways.
Link to Additional Information: http://grants.nih.gov/grants/guide/rfa-files/RFA-AI-21-019.html
Grantor Contact Information: If you have difficulty accessing the full announcement electronically, please contact:

NIH OER Webmaster
grantsinfo@nih.gov
Email:grantsinfo@nih.gov

Version History

Version Modification Description Updated Date

Related Documents

Packages

Agency Contact Information: NIH OER Webmaster
grantsinfo@nih.gov
Email: grantsinfo@nih.gov
Who Can Apply: Organization Applicants

Assistance Listing Number Competition ID Competition Title Opportunity Package ID Opening Date Closing Date Actions
FORMS-F Use for due dates on or after May 25, 2020 PKG00266336 Jul 24, 2021 Aug 24, 2021 View

Package 1

Mandatory forms

332560 RR_SF424_2_0-2.0.pdf

332560 PHS398_CoverPageSupplement_5_0-5.0.pdf

332560 RR_OtherProjectInfo_1_4-1.4.pdf

332560 PerformanceSite_2_0-2.0.pdf

332560 RR_KeyPersonExpanded_2_0-2.0.pdf

332560 PHS398_ResearchPlan_4_0-4.0.pdf

332560 PHSHumanSubjectsAndClinicalTrialsInfo_2_0-2.0.pdf

Optional forms

332560 RR_Budget_1_4-1.4.pdf

332560 RR_SubawardBudget30_1_4-1.4.pdf

332560 PHS398_ModularBudget_1_2-1.2.pdf

332560 PHS_AssignmentRequestForm_3_0-3.0.pdf

2025-07-09T21:19:19-05:00

Share This Post, Choose Your Platform!

About the Author: